About Olaratumab
Class: | Monoclonal antibody (IgG1)
Use: | Treatment of soft tissue sarcoma in combination with doxorubicin in adults
Adult dose: | 15 mg/kg IV infusion once weekly for the first 8 weeks, then every 2 weeks
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Nausea, fatigue, vomiting, diarrhea, hypotension, infusion-related reactions
Contraindications: | Hypersensitivity to olaratumab or any component of the formulation
Storage: | Store at 2°C
Drug Class
Monoclonal antibody (IgG1)
Uses & Indications
Treatment of soft tissue sarcoma in combination with doxorubicin in adults
Storage Requirements
Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: Eli Lilly & Co Inc., U.S.A
Package Size
50ml Vial
Price & Supplier
Price in UAE: AED 8461.00
Dosage Information
Adult Dose
15 mg/kg IV infusion once weekly for the first 8 weeks, then every 2 weeks
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Nausea, fatigue, vomiting, diarrhea, hypotension, infusion-related reactions
Contraindications & Precautions
Hypersensitivity to olaratumab or any component of the formulation
Important Warnings
Risk of severe infusion-related reactions; monitor patients during infusion; potential for increased risk of serious infections and bleeding events
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.